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ABSTRACT 
Primary neuroendocrine tumors of the fallopian tube are extremely rare with a few reported 
cases of high-grade neuroendocrine carcinoma and a single report of a carcinoid tumor 
arising in a teratoma.  We report four cases of probable primary neuroendocrine tumors of the 
fallopian tube (two carcinoid tumors/ low-grade neuroendocrine tumors and two high-grade 
neuroendocrine carcinomas) in patients aged 49-71. These represent the first reported cases 
of primary tubal carcinoid tumor unassociated with a teratoma. We review the published 
literature regarding primary neuroendocrine tumors of the fallopian tube and speculate on the 
possible histogenesis of these neoplasms. 
 
Key words:- fallopian tube, carcinoid tumor, neuroendocrine carcinoma, 
immunohistochemistry. 
 
INTRODUCTION 
Neuroendocrine neoplasms occur at many sites in the body but primary neuroendocrine 
tumors of the fallopian tube are extremely rare with only a few case reports in the literature 
(1-6). There are occasional reports of high-grade neuroendocrine carcinoma of the fallopian 
tube and one reported case of a carcinoid tumor (also currently variously termed low-grade/ 
grade 1 neuroendocrine tumor) associated with a mature cystic teratoma (1-6). However, 
there have been no reports of isolated primary carcinoid tumor (not associated with a 
teratoma) at this location. We report a small series of probable primary neuroendocrine 
tumors involving the fallopian tube, including the first cases of carcinoid tumor unassociated 
with a teratoma. In reporting these cases, we discuss the possible histogenesis and review the 
literature on primary tubal neuroendocrine neoplasms. 
 
MATERIALS AND METHODS 
The cases derived from the pathology archives of the institutions to which the authors are 
affiliated. Clinical details and follow-up information were obtained from the pathology 
reports and liaison with the clinician or consulting pathologist. All available hematoxylin and 
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 3 
eosin-stained slides were examined as well as the immunohistochemistry performed as part 
of the work-up of the cases.  
 
Immunohistochemical staining for chromogranin was performed on 16 normal fallopian 
tubes. 
 
 
CASE REPORTS 
Case 1 
A 49-year-old woman with no significant past history underwent total abdominal 
hysterectomy and bilateral salpingo-oophorectomy for an adnexal mass. Following the 
pathological diagnosis, the patient initially refused further investigations. A year later, she 
underwent an ultrasound of the abdomen and pelvis and a colonoscopy, both of which were 
normal. There was no clinical evidence of tumor elsewhere and the patient was 
asymptomatic. 
 
Both ovaries and fallopian tubes were submitted in their entirety for histological examination. 
Both ovaries contained endometriosis and both tubes showed pseudoxanthomatous salpingitis 
secondary to endometriosis. Sections from the fimbrial ends of both fallopian tubes showed 
multiple (5 to 7 on each side) small microscopic nodules. These comprised small nests of 
cells with regular nuclei with a “salt and pepper” chromatin and abundant basophilic 
cytoplasm. There was no mitotic activity. These foci ranged in size from 0.17 mm to 0.96 
mm, were confined to the fimbrial mucosa and submucosa with no connection to the 
epithelium and there was no lymphovascular space involvement. The cells were diffusely 
positive with synaptophysin, chromogranin, CD56 and CDX2. The Ki67 (MIB1) 
proliferation index was <1%. The morphological and immunohistochemical features were of 
multiple foci of carcinoid tumor/low-grade neuroendocrine tumor. No other tumor 
component was present. 
 
There was a uterine corpus leiomyoma and the cervix was unremarkable. 
 
Figure 1 shows representative images of the carcinoid foci and illustrates some of the 
immunohistochemistry. 
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. 
 
Case 2 
A 61-year-old woman with hereditary breast and ovarian cancer (HBOC), but without a 
BRCA germline mutation, underwent risk reducing bilateral salpingo-oophorectomy and 
hysterectomy. One year earlier, she had surgery for a breast infiltrating ductal carcinoma, 
grade 3, with no neuroendocrine features. The patient had no prior history of a 
neuroendocrine tumor and a whole body Ga-PET-CT scan following the pathology diagnosis 
revealed no tumor elsewhere. 
 
Both fallopian tubes and ovaries (which were grossly normal) were examined in their 
entirety. No tumor was identified macroscopically. However, histological examination 
showed a 1 mm tumor involving the fimbrial end of the right fallopian tube. This was located 
in the mucosa and ulcerated the surface epithelium. The lesion was well circumscribed, but 
not encapsulated, and composed of nests and trabeculae of cells with an organoid appearance. 
The cells had round to ovoid bland nuclei and a moderate amount of eosinophilic cytoplasm. 
There was no mitotic activity. Immunohistochemistry showed diffuse positivity for 
chromogranin, synaptophysin, CD56, WT1 and AE1/3.  p16, estrogen receptor (ER), 
progesterone receptor (PR), PAX8, inhibin, calretinin, CK7, vimentin, GATA3, CDX2 and 
GCDFP-15 were negative. The Ki67 (MIB1) proliferation index was <1%. The morphology 
and immunophenotype were in keeping with a carcinoid tumor/ low-grade neuroendocrine 
tumor. No other tumor component was present. 
 
The left fallopian tube, both ovaries, uterine corpus and cervix showed no gross or 
microscopic abnormality. 
 
Figure 2 shows representative images of the carcinoid tumor and illustrates some of the 
immunohistochemistry. 
 
 
Case 3 
A 69-year-old woman presented with postmenopausal vaginal bleeding. A left adnexal mass 
was identified on PET-CT scan and the serum CA125 was mildly raised at 35 U/ml. 
Radiologically, there was no evidence of tumor outside the left adnexa. The patient 
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underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic 
lymphadenectomy and omentectomy. Following the histological diagnosis, she received 
vincristine, adriamycin and cisplatin chemotherapy. At three years follow-up, she is alive 
without disease. 
 
Grossly, a 4 cm solid tumor involved the left fallopian tube. Histology showed a neoplasm 
involving the full thickness of the wall of the tube and composed of a diffuse arrangement of 
cells with ovoid hyperchromatic nuclei with nuclear moulding. The tumor cells had scant 
cytoplasm. There was high mitotic activity and areas of necrosis. CD56, chromogranin, and 
synaptophysin were diffusely positive. WT1 and p16 were negative and p53 showed a wild-
type pattern of immunoreactivity. The morphology and immunophenotype were in keeping 
with a high-grade neuroendocrine carcinoma of small cell type (small cell neuroendocrine 
carcinoma). No other tumor component was present. 
 
The right fallopian tube, both ovaries, uterine corpus and cervix were grossly and 
histologically normal. The pelvic lymph nodes and omentum were not involved by tumor. 
 
Figure 3 shows representative images of the tumor and illustrates some of the 
immunohistochemistry. 
 
 
Case 4 
A 71-year-old woman presented with postmenopausal vaginal bleeding. An endometrial 
biopsy showed no tumor. MRI revealed a 5 cm left adnexal mass with no tumor elsewhere. 
She underwent hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymph node 
dissection and omentectomy. The postoperative course was complicated by a wound 
infection and the patient died 22 days following the operation. An autopsy was performed 
and showed no evidence of tumor elsewhere. 
 
On gross examination, the tumor involved the left fallopian tube, including the fimbria. 
Histology showed a neoplasm involving the full thickness of the wall of the tube and 
composed of a diffuse and nested arrangement of cells with large nuclei and abundant 
eosinophilic cytoplasm. There was high mitotic activity and areas of necrosis. 
Immunohistochemistry showed diffuse positivity for synaptophysin, chromogranin and 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 6 
CD56. CK7, epithelial membrane antigen (EMA), HMB45, CD45, WT1 and ER were 
negative. The morphology and immunophenotype were in keeping with a high-grade 
neuroendocrine carcinoma of large cell type (large cell neuroendocrine carcinoma). No other 
tumor component was present. 
 
Three of 8 left pelvic lymph nodes contained metastatic tumor; the 7 right pelvic lymph 
nodes were uninvolved. The right fallopian tube, both ovaries, uterine corpus and cervix were 
grossly and histologically normal. The omentum was not involved by tumor. 
 
Figure 4 shows representative images of the tumor and illustrates some of the 
immunohistochemistry. 
 
 
IMMUNOHISTOCHEMICAL STAINING OF NORMAL FALLOPIAN TUBES 
Of the 16 normal fallopian tubes, 9 showed mucosal epithelial cells which exhibited positive 
cytoplasmic staining with chromogranin (figure 5). The number of positive cells varied 
greatly from occasional scattered cells to many cells. 
 
 
 
DISCUSSION 
We report four cases of probable primary neuroendocrine tumors of the fallopian tube (two 
carcinoid tumors/ low-grade neuroendocrine tumors and two high-grade neuroendocrine 
carcinomas), the first reported series in the literature. Primary neuroendocrine tumors of the 
fallopian tube are extremely rare and, in fact, the category of neuroendocrine tumor is not 
included in the 2014 World Health Organization (WHO) Classification of tumors of the 
female reproductive organs (7). There have been only occasional case reports in the literature 
of a primary neuroendocrine tumor at this location (1-6). In one case, a carcinoid tumor arose 
within a mature cystic teratoma of the fallopian tube. Although morphologically low-grade, 
the tumor had spread to involve both ovaries and the serosal surface of the uterus at the time 
of presentation (1). There are a few reports of primary tubal high-grade neuroendocrine 
carcinomas (2-6), including one admixed with a component of serous carcinoma, but we are 
not aware of any reports of isolated low-grade neuroendocrine tumor unassociated with a 
teratoma at this site.  
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The differential diagnosis of the carcinoid tumors (low-grade neuroendocrine tumors) is 
limited, given the characteristic morphology and positivity for neuroendocrine markers 
chromogranin and synaptophysin. Microscopic sex cord-like proliferations resembling adult 
granulosa cell tumor or sex cord tumor with annular tubules (SCTAT) have recently been 
reported involving the fallopian tube and might be considered in the differential diagnosis. 
However, the nuclear characteristics of these sex cord proliferations are morphologically 
distinct to carcinoid tumors and they have a different immunophenotype being positive with 
sex cord markers inhibin and calretinin (8). In the context of a patient with HBOC (case 2), 
including those with a BRCA germline mutation, the differential diagnosis might include 
serous tubal intraepithelial carcinoma (STIC) or high-grade serous carcinoma arising in the 
fallopian tube or metastatic breast carcinoma. Again, however, the morphologic features and 
immunophenotype are distinct and allow easy distinction from a low-grade neuroendocrine 
tumor.  
 
High-grade neuroendocrine carcinomas may be of small cell or large cell type. The 
differential diagnosis of high-grade neuroendocrine carcinomas depends on whether this is 
predominantly of small cell or large cell type but in the fallopian tube potentially includes 
other high-grade epithelial neoplasms, such as high-grade serous or endometrioid carcinoma. 
Again the morphological features and a combination of immunohistochemical markers 
should allow ready distinction; high-grade serous and endometrioid carcinomas are usually 
PAX8 and ER positive while high-grade neuroendocrine carcinomas are generally negative. 
High-grade serous carcinomas are usually WT1 positive and high-grade neuroendocrine 
carcinomas generally negative. 
 
A key issue in the cases we report is whether the neuroendocrine tumors represent primary 
tubal lesions or metastases from other anatomic sites. Immunohistohemistry is of limited 
value in this distinction since neuroendocrine neoplasms at various sites generally exhibit a 
broadly similar immunophenotype. For example, CDX2 is commonly positive in mid-gut 
carcinoid tumors but is also positive in ovarian carcinoids of insular type which commonly 
arise in teratomas and which are morphologically equivalent to mid-gut carcinoids (9). One 
of the carcinoids in our series was CDX2 positive. A metastasis was especially considered in 
case 1 since both fallopian tubes contained multiple small foci of carcinoid tumor. In all our 
cases, there was no clinical or radiological evidence of neuroendocrine tumor elsewhere at 
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presentation or on follow-up (one patient underwent an autopsy which revealed no evidence 
of tumor elsewhere); however, as stated, particularly in case 1 we cannot exclude metastasis. 
Nevertheless, the evidence available in each case supports the interpretation that these 
probably represent primary tubal lesions. 
 
The histogenesis of primary carcinoid tumor (low-grade neuroendocrine tumor) of the 
fallopian tube is unclear. Possibilities include an origin from a teratoma (which are extremely 
rare in the fallopian tube) or as a neuroendocrine component of another tumor type. There 
was no evidence of any other tumor type in the two cases we report and total overgrowth of 
another neoplasm is highly unlikely given that the tumors were small and incidentally 
detected microscopic lesions. Another possibility is that they arise from dispersed 
neuroendocrine cells in the fallopian tube. To investigate whether neuroendocrine positive 
cells are present in the normal fallopian tube, we stained 16 tubes and chromogranin positive 
mucosal epithelial cells were present in 9 cases. It is possible that these are the origin of 
primary neuroendocrine tumors of the fallopian tube, especially low-grade neoplasms and we 
are not aware of neuroendocrine cells having been demonstrated in normal fallopian tubes 
previously. A similar histogenesis may apply to primary tubal high-grade neuroendocrine 
carcinomas. When these neoplasms arise at other sites within the female genital tract (cervix, 
endometrium, ovary), they often occur in association with another tumor type (10-18). While 
the two high-grade neuroendocrine carcinomas we report occurred in pure form (with no 
other tumor component), it is possible that another component was present and totally 
overgrown by the neuroendocrine neoplasm. One of the prior reported cases of primary tubal 
high-grade neuroendocrine carcinoma also contained a component of serous carcinoma (6). 
 
In conclusion, we report four cases of probable primary neuroendocrine tumors of the 
fallopian tube, including the first reports of a primary carcinoid tumor/ low-grade 
neuroendocrine tumor not associated with a teratoma. Given the increased focus on the 
fallopian tube fimbria as the site of origin of extrauterine high-grade serous carcinoma, 
fallopian tubes are now more extensively examined and it is possible that additional cases, 
especially of microscopic carcinoid tumors, will be identified in the future. 
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FIGURE LEGENDS 
Figure 1. Case 1. Focus of carcinoid tumor in wall of fallopian tube (A). Higher power 
view showing carcinoid tumor just deep to surface epithelium of fallopian tube (B). 
Chromogranin stain highlighting several foci of carcinoid tumor (C and D). 
 
Figure 2. Case 2. Low power view showing microscopic carcinoid tumor involving 
mucosa of fallopian tube (A and B). On higher power, the regular tumor cells grow in nests 
and trabeculae (C). The tumor cells are diffusely positive with chromogranin (D). 
 
Figure 3. Case 3. High-grade neuroendocrine carcinoma (small cell neuroendocrine 
carcinoma) involving fimbria of fallopian tube (A). On higher power, the tumor cells exhibit 
a diffuse growth pattern and contain scant cytoplasm (B). The tumor cells are diffusely 
positive with synaptophysin (C). 
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Figure 4. Case 4. High-grade neuroendocrine carcinoma (large cell neuroendocrine 
carcinoma) involving fimbria of fallopian tube (A). On higher power, the tumor cells exhibit 
a diffuse growth pattern and contain abundant cytoplasm (B). The tumor cells are diffusely 
positive with synaptophysin (C). 
 
Figure 5.  Normal fallopian tube with chromogranin positive epithelial cells. 
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